Session: Innovative Organizational Responses to Issues in the Pharmaceutical Sector


Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

3035.0: Monday, December 12, 2005: 8:30 AM-10:00 AM

Oral

Innovative Organizational Responses to Issues in the Pharmaceutical Sector

At the global level, the issues surrounding the pharmaceutical sector spotlight real and potential conflicts between free market enterprise and public health policy. The pharmaceutical industry is a powerful engine in global economic development, and shocks to that industry can send the stock market index down. Industry development strategies are naturally designed to maximize profits in lucrative (and relatively healthy) markets with minimal attention to maximizing health status around the world, and these strategies have attracted increasing sharp criticism from civil society, which sees health as a human right and public good. This panel will include presentations on four recently established and innovative organizations who are responding to these basic conflicts in the pharmaceutical sector.

Learning Objectives: At the conclusion of the session, the participant will be able to (1) describe how economic incentives and health as a public good are in conflict within the pharmaceutical sector; (2) describe, discuss and evaluate creative organizational responses to this conflict.

Organizer(s):

Maggie Huff-Rousselle, MA, MBA, PhD

Moderator(s):

Maggie Huff-Rousselle, MA, MBA, PhD

8:30 AM

Introductory Remarks

8:35 AM

Innovative Organizational Responses to Issues in the Pharmaceutical Sector: The Alliance